Effectiveness of oral fluoropyrimidine monotherapy as adjuvant chemotherapy for high-risk stage II colon cancer

PURPOSE: The benefit of adjuvant chemotherapy for stage II colon cancer has not been clearly demonstrated even in cases with high-risk factors. This study aimed to compare the effectiveness of oral fluoropyrimidine monotherapy as adjuvant chemotherapy with that of intravenous fluoropyrimidine-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Jung Rae, Lee, Keun-Wook, Oh, Heung-Kwon, Kim, Jin Won, Kim, Ji-Won, Kim, Duck-Woo, Kim, Jee Hyun, Kang, Sung-Bum
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Surgical Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111961/
https://www.ncbi.nlm.nih.gov/pubmed/35611086
http://dx.doi.org/10.4174/astr.2022.102.5.271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111961/
https://www.ncbi.nlm.nih.gov/pubmed/35611086
http://dx.doi.org/10.4174/astr.2022.102.5.271

Ejemplares similares